
Why transformation is a buzzword at Piramal
Billionaire industrialist Ajay Piramal is in makeover mode. He wants to remould his conglomerate into a well-diversified NBFC and a pharma firm, which would both be giants in their respective spaces.
Billionaire industrialist Ajay Piramal is in makeover mode. He wants to remould his conglomerate into a well-diversified NBFC and a pharma firm, which would both be giants in their respective spaces.
After a long time, the Union Budget has brought back a renewed focus on healthcare and health infrastructure, which it aims to achieve through a slew of measures. The health industry is elated.
As we look ahead to immunisation in 2021, there is the fear of adverse reactions to the drugs as the vaccines have been tested for less than six months. But a framework exists to deal with such cases.
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
Benchmark indices record their biggest single-day gain since May 2009.
Structural changes in the global pharma industry are throwing up challenges and opportunities. Enter Cipla with its expertise in medicine, and vision for relevance beyond pharma.
B.R. Shetty plans to pump in billions of dollars as part of his plan to open 20,000 hospital beds in India over the next 10 years. Given the churn in the healthcare sector, will he succeed?
With a strong distribution network, FMCG companies are shifting gears and preparing to cater to the needs of a more health conscious rural population with OTC medical products.
Studies have highlighted the multiple benefits that telemedicine lends to screening, including TB detection, PAP smear for cervical cancer and mammogram analysis for breast cancer.
Biocon CMD Kiran Mazumdar Shaw speaks to Fortune India on the sidelines of the USIBC India Ideas Summit; says U.S. and India are natural synergistic partners.